RESPONSE OF HUMAN ENDOMETRIUM AND OVARIAN-CARCINOMA CELL-LINES TO PHOTODYNAMIC THERAPY

被引:17
作者
RAAB, GH
SCHNEIDER, AF
EIERMANN, W
GOTTSCHALKDEPONTE, H
BAUMGARTNER, R
BEYER, W
机构
[1] UNIV MUNICH,KLINIKUM GROSSHADERN,DEPT GYNECOL,MARCHIONISTR 15,W-8000 MUNICH 70,GERMANY
[2] GESELL STRAHLEN & UMWELTFORSCH MBH,CENT LASER LAB,MUNICH NEUHERBERG,GERMANY
关键词
Cell culture; Gynecological tumors; Photodynamic therapy; Photosensitizer;
D O I
10.1007/BF02389584
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
The response of the human gynecological carcinoma cell-lines HEC-1-A (endometrial carcinoma) and OvCar-3 (ovarian carcinoma) to photodynamic therapy in vitro was examined. The porphyrin compound Photosan III® (Ph III) was used for photosensitization of the cells after incubation times of 24 h (HEC-1-A) and 48 h (HEC-1-A and OvCar-3). The Ph III doses varied from 0-10 μg/ml medium. Irradiation was performed with laser light at 630 nm. Irradiation doses up to 20 J/cm2 were applied at an irradiance of 40-100 mW/cm2. Cell vitality of the untreated control groups and of the therapy group was determined 48 h after irradiation, using the trypan blue exclusion test. The experimental results show that treatment of OvCar-3 cells with 10 J/cm2 resulted in a decrease in vitality dependent on photosensitizer dose (0-5 μg/ml, 48 h incubation time) but independent of the irradiance (40-100 mW/cm2). Complete cell death was observed after application of irradiation doses in the range of 5-20 J/cm2 combined with drug concentrations of 10-2.5 μg/ml, at a fixed incubation time of 48 h. HEC-1-A cells did not survive photodynamic therapy with 10 J/cm2 after incubation with 5 μg/ml for 48 h. After a shorter incubation time of 24 h, 10 μg/ml Ph III was necessary for the same effect. There was a maximum decrease in cell vitality when measured 48 h after irradiation. This was not improved at 72 h. © 1990 Springer-Verlag.
引用
收藏
页码:13 / 20
页数:8
相关论文
共 32 条
[1]   TREATMENT OF TRANSITIONAL CELL-CARCINOMA OF THE BLADDER WITH HEMATOPORPHYRIN DERIVATIVE PHOTOTHERAPY [J].
BENSON, RC ;
KINSEY, JH ;
CORTESE, DA ;
FARROW, GM ;
UTZ, DC .
JOURNAL OF UROLOGY, 1983, 130 (06) :1090-1095
[2]  
BERNS M W, 1983, Lasers in Surgery and Medicine, V2, P261, DOI 10.1002/lsm.1900020309
[3]   EXPOSURE (DOSE) TABLES FOR HEMATOPORPHYRIN DERIVATIVE PHOTORADIATION THERAPY [J].
BERNS, MW ;
BERNS, GS ;
COFFEY, J ;
WILE, AG .
LASERS IN SURGERY AND MEDICINE, 1984, 4 (01) :107-131
[4]  
CHRISTENSEN T, 1984, PORPHYRINS TUMOR PHO, P151
[5]  
DAHLMAN A, 1983, CANCER RES, V43, P430
[6]  
DOUGHERTY TJ, 1978, CANCER RES, V38, P2628
[7]   PHOTOTHERAPY OF HUMAN-TUMORS USING HEMATOPORPHYRIN DERIVATIVE [J].
FORBES, IJ ;
COWLED, PA ;
LEONG, ASY ;
WARD, AD ;
BLACK, RB ;
BLAKE, AJ ;
JACKA, FJ .
MEDICAL JOURNAL OF AUSTRALIA, 1980, 2 (09) :489-493
[8]  
GIBSON SL, 1983, CANCER RES, V43, P4191
[9]  
GOMER CJ, 1979, CANCER RES, V39, P146
[10]  
GOMER CJ, 1985, CANCER RES, V45, P1973